Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evgeny Klyuchnikov

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|April 7, 2009
Sensitising leukemic cells by targeting microenvironmentEvgeny Klyuchnikov, Nicolaus Kroger
Expert Opinion on Drug Safety|June 10, 2009
Safety of conditioning agents for allogeneic haematopoietic transplantationUlrike Bacher, Evgeny Klyuchnikov, Bettina Wiedemann, et al.
Frontiers in Immunology|April 1, 2021
TKI Maintenance After Stem-Cell Transplantation for <i>FLT3</i>-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-AnalysisNico Gagelmann, Christine Wolschke, Evgeny Klyuchnikov, et al.
Haematologica|February 23, 2023
Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patientsNico Gagelmann, Francis A Ayuk, Evgeny Klyuchnikov, et al.
Bone Marrow Transplantation|January 20, 2022
Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosisDaniele Mannina, Anita Badbaran, Christine Wolschke, et al.
European Journal of Haematology|October 17, 2023
Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomasRadwan Massoud, Hassan Naim, Evgeny Klyuchnikov, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2009
Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML)Evgeny Klyuchnikov, Nicolaus Kröger, Tim H Brummendorf, et al.
Advances in Hematology|October 29, 2010
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma PatientsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus Kröger, et al.
Acta Haematologica|March 18, 2011
Challenges for allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia in the era of tyrosine kinase inhibitorsAnthony Oyekunle, Evgeny Klyuchnikov, Sunday Ocheni, et al.
Advances in Hematology|November 24, 2011
Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemiaAnthony Oyekunle, Torsten Haferlach, Nicolaus Kröger, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|April 7, 2009
Sensitising leukemic cells by targeting microenvironmentEvgeny Klyuchnikov, Nicolaus Kroger
Expert Opinion on Drug Safety|June 10, 2009
Safety of conditioning agents for allogeneic haematopoietic transplantationUlrike Bacher, Evgeny Klyuchnikov, Bettina Wiedemann, et al.
Frontiers in Immunology|April 1, 2021
TKI Maintenance After Stem-Cell Transplantation for <i>FLT3</i>-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-AnalysisNico Gagelmann, Christine Wolschke, Evgeny Klyuchnikov, et al.
Haematologica|February 23, 2023
Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patientsNico Gagelmann, Francis A Ayuk, Evgeny Klyuchnikov, et al.
Bone Marrow Transplantation|January 20, 2022
Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosisDaniele Mannina, Anita Badbaran, Christine Wolschke, et al.
European Journal of Haematology|October 17, 2023
Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomasRadwan Massoud, Hassan Naim, Evgeny Klyuchnikov, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2009
Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML)Evgeny Klyuchnikov, Nicolaus Kröger, Tim H Brummendorf, et al.
Advances in Hematology|October 29, 2010
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma PatientsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus Kröger, et al.
Acta Haematologica|March 18, 2011
Challenges for allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia in the era of tyrosine kinase inhibitorsAnthony Oyekunle, Evgeny Klyuchnikov, Sunday Ocheni, et al.
Advances in Hematology|November 24, 2011
Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemiaAnthony Oyekunle, Torsten Haferlach, Nicolaus Kröger, et al.
Pageof 7